A fascinating discussion popped-up today around strategies and tactics that pharma should use to engage with social media. Johnathan over at dose of digital started this discussion with this list …
Great news, we've signed you up.
Sorry, we weren't able to sign you up. Please check your details, and try again.
MS patient meets German clinical trial
Becoming a "patient-like-me" in EU
© 2009 whydot pharma
Powered by WordPress. Repro Theme by Orman Clark